Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China

Chinese Medical Journal

Volumn 127, Issue 7, 2014, Pages 1239-1243

  Cao, Hai Long ^a   Qu, Rui ^b   Zhang, Zhi Hua ^c   Kong, Xin Yue ^a   Wang, Shan ^a   Jiang, Kui ^a   Wang, Bang Mao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b DONGYING PEOPLE S HOSPITAL   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Esophagogastroduodenoscopy; Fundic gland polyps; Helicobacter pylori; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DYSPEPSIA; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SPORADIC FUNDIC GLAND POLYP; STOMACH GLAND POLYP; STOMACH MUCOSA; ADENOMATOUS POLYPS; AGED; CHINA; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFECTS; HELICOBACTER INFECTIONS; PATHOLOGY; STOMACH FUNDUS; STOMACH NEOPLASMS;

ADENOMATOUS POLYPS; ADULT; AGED; CHINA; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GASTRIC FUNDUS; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84897943542     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20133068     Document Type: Article

References (32)

1. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol 2001; 158: 1005-1010.
2. Samarasam I, Roberts-Thomson J, Brockwell D. Gastric fundic gland polyps: a clinico-pathological study from North West Tasmania. ANZ J Surg 2009; 79: 467-470.
3. Hongo M, Fujimoto K. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol 2010; 45: 618-624.
4. Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, et al. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci 2009; 54: 2617-2622.
5. Cao H, Wang B, Zhang Z, Zhang H, Qu R. Distribution trends of gastric polyps: an endoscopy database analysis of 24 121 northern Chinese patients. J Gastroenterol Hepatol 2012; 27: 1175-1180.
6. Burt RW. Gastric fundic gland polyps. Gastroenterology 2003; 125: 1462-1469.
7. Torbenson M, Lee JH, Cruz-Correa M, Ravich W, Rastgar K, Abraham SC, et al. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol 2002; 15: 718-723.
8. Cao HL, Song SL, Yang BL, Zhang ZH, Zhang H, Qu R, et al. Typical endoscopic appearance accurately predicts sporadic fundic gland polyps: a retrospective study of 47 771 endoscopies. Chin Med J 2013; 126: 2984-2986.
9. Chubineh S, Birk J. Proton pump inhibitors: the good, the bad, and the unwanted. South Med J 2012; 105: 613-618.
10. Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust 1992; 157: 287-288.
11. Zelter A, Fernández JL, Bilder C, Rodríguez P, Wonaga A, Dorado F, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1 780 endoscopies. Dig Dis Sci 2011; 56: 1743-1748.
12. Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24: 1341-1348.
13. el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol 1997; 92: 1858-1860.
14. Graham JR. Gastric acne: omeprazole-induced fundic gland polyposis. Med J Aust 1998; 168: 93.
15. Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrasound characteristics. Am J Chin Pathol 1998; 110: 615-621.
16. Driman DK, Wright C, Tougas G, Riddell RH. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci 1996; 41: 2039-2047.
17. Pregun I, Herszényi L, Juhász M, Miheller P, Hritz I, Patócs A, et al. Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion 2011; 84: 22-28.
18. Hassall E, Dimmick J, Israel D. Parietal cell hyperplasia in children receiving omeprazole (abstract). Gastroenterology 1995; 108: A12.
19. Declich P, Tavani E, Ferrara A, Caruso S, Bellone S. Sporadic fundic gland polyps: clinico-pathologic features and associated diseases. Pol J Pathol 2005; 56: 131-137.
20. Stolte M, Bethke B, Seifert E, Armbrecht U, Lütke A, Goldbrunner P, et al. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol 1995; 33: 146-149.
21. Stole M. Fundic gland polyps: a rare, innocuous, and reversible disturbance (letter). Gastroenterology 1993; 105: 1590-1591.
22. Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia: evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol 2002; 161: 1735-1742.
23. Abraham SC, Park SJ, Cruz-Correa M. Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps. Am J Clin Pathol 2004; 122: 740-746.
24. Wei J, Chiriboga L, Yee H. Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps. Mod Pathol 2002; 15: 862-869.
25. Pashankar DS, Israel DM. Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr 2002; 35: 658-662.
26. Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 2001; 116: 716-720.
27. Metz DC. Managing gastroesophageal reflux disease for the lifetime of the patient: evaluating the long-term options. Am J Med 2004; 117: 49S-55S.
28. Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G. Pharmacology and toxicology of omeprazole with special reference to the effects of the gastric mucosa. Scand J Gastroenterol 1986; 21: 31-38.
29. Watanabe N, Seno H, Nakajima T, Yazumi S, Miyamoto S, Matsumoto S, et al. Regression of fundic gland polyps following acquisition of Helicobacter pylori. Gut 2002; 51: 742-745.
30. Shand AG, Taylor AC, Banerjee M, Lessels A, Coia J, Clark C, et al. Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol 2002; 17: 1161-1164.
31. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, van der Merwe S, et al. World Gastroenterology Organization: Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis 2011; 20: 299-304.
32. Cats A, Schenk BE, Bloemena E. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol 2000; 31: 684-690.